0.00
Mei Pharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
See More
Previous Close:
$3.07
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$100.81M
Revenue:
$105.38M
Net Income/Loss:
$17.78M
P/E Ratio:
0.00
EPS:
2.67
Net Cash Flow:
$-50.48M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
Mei Pharma Inc Stock (MEIP) Company Profile
Name
Mei Pharma Inc
Sector
Industry
Phone
858-369-7100
Address
11455 EL CAMINO REAL, SAN DIEGO, CA
Compare MEIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MEIP
Mei Pharma Inc
|
0.00 | 100.81M | 105.38M | 17.78M | -50.48M | 2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.25 | 105.80B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
646.87 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
440.49 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
851.01 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.68 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Laidlaw | Buy → Hold |
| Mar-25-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-25-22 | Downgrade | Stifel | Buy → Hold |
| Mar-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-03-22 | Initiated | Jefferies | Buy |
| Sep-22-20 | Initiated | Alliance Global Partners | Buy |
| May-29-20 | Initiated | SunTrust | Buy |
| Dec-20-18 | Initiated | H.C. Wainwright | Buy |
| Jul-27-18 | Upgrade | Stifel | Hold → Buy |
| Jul-13-18 | Initiated | SunTrust | Buy |
| Apr-18-16 | Reiterated | Wedbush | Neutral |
| Mar-23-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-18-14 | Reiterated | ROTH Capital | Buy |
| Oct-16-14 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
| Oct-22-13 | Reiterated | Stifel | Buy |
| Apr-15-13 | Initiated | Stifel | Buy |
View All
Mei Pharma Inc Stock (MEIP) Latest News
Will MEI Pharma Inc. continue its uptrendShort Setup & Real-Time Volume Triggers - newser.com
Is MEI Pharma Inc. (MMI0) stock expanding market penetrationQuarterly Portfolio Summary & Stepwise Trade Signal Implementation - newser.com
Is MEI Pharma Inc. (MMI0) stock undervalued historicallyMarket Risk Report & Consistent Income Trade Recommendations - newser.com
Will MEI Pharma Inc. stock benefit from automation2025 Big Picture & Short-Term High Return Strategies - newser.com
How to use a screener to detect MEI Pharma Inc. breakouts2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Is a relief rally coming for MEI Pharma Inc. holdersMarket Risk Report & Fast Moving Stock Watchlists - newser.com
Why retail investors favor MEI Pharma Inc. stockWeekly Profit Analysis & Reliable Momentum Entry Alerts - fcp.pa.gov.br
Can MEI Pharma Inc. stock deliver consistent earnings growth2025 Bull vs Bear & Real-Time Price Movement Reports - fcp.pa.gov.br
Risk adjusted return profile for MEI Pharma Inc. analyzedMarket Growth Report & Risk Managed Investment Entry Signals - newser.com
Why MEI Pharma Inc. (MMI0) stock could be top winnerEarnings Beat & Reliable Trade Execution Plans - newser.com
MEI Pharma Inc. stock prediction for this weekJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
Is MEI Pharma Inc. forming a reversal pattern2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Is MEI Pharma Inc. (MMI0) stock included in top ETFs2025 Momentum Check & Stock Portfolio Risk Management - newser.com
Can MEI Pharma Inc. stock beat market expectations this quarterWeekly Market Report & Verified Stock Trade Ideas - newser.com
Can MEI Pharma Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Safe Capital Allocation Plans - newser.com
Will MEI Pharma Inc. stock reach Wall Street targetsTrade Entry Summary & Scalable Portfolio Growth Ideas - newser.com
How robust is MEI Pharma Inc. (MMI0) stock financial positionJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Can volume confirm reversal in MEI Pharma Inc.Trade Volume Report & Risk Controlled Daily Trade Plans - newser.com
Can MEI Pharma Inc. hit a new high this monthTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Multi asset correlation models including MEI Pharma Inc.2025 Buyback Activity & Consistent Profit Alerts - newser.com
How MEI Pharma Inc. stock benefits from strong dollarQuarterly Market Summary & Risk Controlled Daily Trade Plans - newser.com
Is MEI Pharma Inc. stock a buy for dividend growthJuly 2025 Gainers & Weekly Return Optimization Alerts - newser.com
Is MEI Pharma Inc. (MMI0) stock a fit for income portfoliosWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
Can MEI Pharma Inc. (MMI0) stock withstand sector downturnsEarnings Beat & Weekly High Potential Stock Alerts - newser.com
Will MEI Pharma Inc. stock deliver strong dividend growthPortfolio Performance Report & Safe Capital Growth Plans - newser.com
Will MEI Pharma Inc. (MMI0) stock rise with strong economyWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
Comparing MEI Pharma Inc. in custom built stock radarsWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
What candlestick patterns are forming on MEI Pharma Inc.July 2025 Institutional & Risk Controlled Daily Plans - newser.com
Mei Pharma Inc Stock (MEIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):